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Human linkage analyses have implicated theMS4A2-
containing gene locus (encoding FcεRIb) as a candi-
date for allergy susceptibility. We have identified a
truncation of FcεRIb (t-FcεRIb) in humans that con-
tains a putative calmodulin-binding domain and
thus, we sought to identify the role of this variant in
mast cell function. We determined that t-FcεRIb is
critical for microtubule formation and degranulation
and that it may perform this function by trafficking
adaptor molecules and kinases to the pericentroso-
mal and Golgi region in response to Ca2+ signals.
Mutagenesis studies suggest that calmodulin bind-
ing to t-FcεRIb in the presence of Ca2+ could be crit-
ical for t-FcεRIb function. In addition, gene targeting
of t-FcεRIb attenuated microtubule formation,
degranulation, and IL-8 production downstream of
Ca2+ signals. Therefore, t-FcεRIb mediates Ca2+-
dependent microtubule formation, which promotes
degranulation and cytokine release. Because
t-FcεRIb has this critical function, it represents a
therapeutic target for the downregulation of allergic
inflammation.
INTRODUCTION
Aggregation of high affinity receptors for immunoglobulin E (IgE)
(FcεRI) by multivalent Ag initiates mast cell (MC) activation and
release of chemical mediators that initiate allergic inflammation
(reviewed in Gilfillan and Rivera, 2009; Gilfillan and Tkaczyk,
2006; Rivera and Gilfillan, 2006). The FcεRI, expressed on MC,
exists as a tetrameric receptor complex comprising an IgE-
binding a chain with a single transmembrane domain, a tetra-
transmembrane-spanning b chain (encoded by the MS4A2
gene), and a disulphide-linked homodimer of signal-transducing
g chains (Kinet, 1999). The FcεRIa subunit binds IgE with high
affinity, but FcεRI signaling is mediated by immunoreceptor
tyrosine-based activation motifs (ITAMs) in the cytoplasmic906 Immunity 38, 906–917, May 23, 2013 ª2013 Elsevier Inc.domains of the FcεRIg subunits. These recruit and activate
Syk kinase, initiating the signaling cascade (Gilfillan and Rivera,
2009; Gilfillan and Tkaczyk, 2006; Rivera and Gilfillan, 2006). The
FcεRIb subunit also has signaling capabilities, imparted through
its noncanonical ITAM near the C terminus. Upon phosphoryla-
tion, the FcεRIb ITAM binds Lyn kinase leading to the recruitment
and phosphorylation of Syk kinase, thus amplifying FcεRIg-
mediated signaling (Gilfillan and Tkaczyk, 2006; Lin et al.,
1996; Rivera and Gilfillan, 2006). In mice, FcεRIb also amplifies
FcεRI signaling by promoting the assembly, stabilization, and
trafficking of the receptor complex to the cell surface (Donnadieu
et al., 2000b; Ra et al., 1989; Singleton et al., 2009).
The gene locus containingMS4A2 has strong linkage to allergy
susceptibility (Cookson et al., 1989; Laprise et al., 2000; Sand-
ford et al., 1993). Given the known functions of FcεRIb, MS4A2
was thus considered as a candidate gene for the development
of allergy and asthma (Sandford et al., 1993; Shirakawa et al.,
1994). However, studies investigating the functional conse-
quence of the asthma-associated mutations in MS4A2 were
disappointing because transfection of the mutant forms showed
no effect on FcεRIb function (Donnadieu et al., 2000a). More
recently, mutations in the predicted transcription promoter re-
gion forMS4A2 have been identified (Kim et al., 2006; Nishiyama
et al., 2004), but the implications of these findings are not yet
clear.
We recently identified a truncated splice variant of FcεRIb
(t-FcεRIb) (GenBank: JF411082.1) in human (Hu)MC which lacks
exon 3, leading to loss of the first two transmembrane domains
(Cruse et al., 2010) that are required for binding to FcεRIa and
receptor trafficking (Singleton et al., 2009). As a result, this
variant does not traffic to the plasma membrane but has a
more diffuse distribution with evidence of nuclear membrane
and perinuclear localization (Cruse et al., 2010). Whether
t-FcεRIb plays a role in Ag-mediated MC activation is unknown
but, because t-FcεRIb retains the C-terminal ITAM, (Cruse et al.,
2010) we have examined the hypothesis that t-FcεRIb retains
signaling capability. On the basis of an examination of the
comparative roles of FcεRIb and t-FcεRIb splice variants in
HuMC signaling, we present data that support the conclusion
that t-FcεRIb propagates Ca2+ signals initiating microtubule
formation and thereby promotes mediator release. Therefore,
we demonstrate that t-FcεRIb plays an important role in mast
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Figure 1. Validation of FcεRIb Silencing in
LAD-2 HuMC
(A) shMS4A2v1 silenced both FcεRIb variants with
low efficiency. shMS4A2v2 selectively silenced
FL-FcεRIb without accompanied silencing of
t-FcεRIb. shMS4A2v3 silenced both variants with
high efficiency. Data are means ± SEM (n = 3).
*p < 0.05.
(B) Silencing the different constructs for FcεRIb
also resulted in a reduction in FcεRIb protein levels.
Two bands were detected in BMMC, which cor-
responded to the predicted size of the FcεRIb
variants (28 and22 kDa). These bands were not
present in Ms4a2/ BMMC. Data are represen-
tative of at least two separate blots.
(C) The reduction in FL-FcεRIb mRNA expression
correlates well with the reduction in FL-FcεRIb
protein levels. Each point represents the mean
expression from the different shRNA constructs.
R2 = 0.964, p = 0.018.
(D) Silencing of FL-FcεRIb, shMS4A2v2 (top
panels), and both FcεRIb variants, shMS4A2v3
(bottom panels), reduced FcεRIa expression
without affecting KIT expression. Both surface
expression of FcεRIa and total expression
of FcεRIa (permeabilized cells) significantly
decreased following transduction. Histograms are
representative of at least three separate experi-
ments. Gray line represents isotype control, black
line represents scramble control, and dashed line
represents shRNA constructs.
See also Figure S1.
Immunity
Truncated FcεRIb Regulates Mast Cell Degranulationcell degranulation and could thus contribute to the allergic
response.
RESULTS
Validation of shRNA Targeting of FcεRIb Variants
The two variants of FcεRIb expressed in HuMC (full-length
[FL]-FcεRIb and t-FcεRIb) were analyzed independently by tar-
geting the exon 2-exon 3 boundary as we described (Cruse
et al., 2010). T-FcεRIb lacks exon 3 and can be identified inde-
pendently of FL-FcεRIb (see Figures S1A and S1B available
online). The functions of the protein products were explored
following small hairpin RNA (shRNA)-mediated FcεRIb silencing.
The efficacy of three shRNA constructs (MS4A2v1, MS4A2v2,
and MS4A2v3) to reduce FcεRIb expression was initially exam-
ined. shMS4A2v1 targets exon 7 of FcεRIb, whereas shMS4A2v2
targets exon 3 so should not affect t-FcεRIb expression because
this lacks exon 3. shMS4A2v3 targets the exon 1–2 boundary
(Figure S1A).Immunity 38, 906–All shRNA constructs reduced FL-
FcεRIbmRNA expression to some degree
at day 7 postinfection. The most effec-
tive construct was shMS4A2v3, which
silenced both variants of FcεRIb with
equal efficacy. shMS4A2v1 silenced
both variants but with lower efficacy than
shMS4A2v3. Importantly, shMS4A2v2
effectively silenced FL-FcεRIb while
having minimal impact on t-FcεRIb expression (Figure 1A).
Thus, to examine the relative role(s) of t-FcεRIb and FcεRIb
in MC function, we compared the differential abilities of
shMS4A2v2 and shMS4A2v3 to modulate defined responses in
LAD-2 HuMC in subsequent studies.
We next confirmed that silencing of mRNA resulted in reduc-
tion of FcεRIb protein expression.We observed that two proteins
of 22 kDa and 28 kDa were expressed in WT mouse bone
marrow-derived MC (mBMMC) and the LAD-2 HuMC line
(Figure 1B) but were absent in Ms4a2/ mBMMC. At 7 days
postinfection, FL-FcεRIb protein expression with silencing was
reduced (Figure 1B; Figure S1C). There was excellent correlation
between the degree ofmRNA and protein reduction of FL-FcεRIb
with the different shRNA constructs (Figure 1C). FcεRIb silencing
in mBMMC reduced expression of both variants. In the LAD-2
HuMC, shMS4A2v2 preferentially silenced FL-FcεRIb over
t-FcεRIb and shMS4A2v3 silenced both variants (Figure 1B).
Taken together, these data indicate that FcεRIb isoforms can
be differentially silenced by using the shRNA constructs tested.917, May 23, 2013 ª2013 Elsevier Inc. 907
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Truncated FcεRIb Regulates Mast Cell DegranulationFcεRIb Gene-Targeting Reduces FcεRIa Surface
Expression without Affecting KIT Expression
Because FcεRIb is required for FcεRI surface expression in the
mouse, and may facilitate FcεRI expression in humans (Donna-
dieu et al., 2000a), we examined the effects of FcεRIb silencing
on the surface expression of both FcεRIa and KIT in LAD-2
HuMC. Silencing of FL-FcεRIb (shMS4A2v2) and simultaneous
silencing of both FcεRIb variants (shMS4A2v3) had no substan-
tial effect on KIT expression either at the cell surface or within
permeabilized cells (Figure 1D). However, as expected, both
constructs reduced the expression of FcεRIa at the cell surface
(Figure 1D; Figure S1D). Permeabilization of the cells did not sub-
stantially change the degree of FcεRIa staining (Figure 1D). The
degree of FL-FcεRIb protein expression with silencing closely
matched the amount of surface FcεRIa expression (Figure S1E).
There was no difference between silencing of FL-FcεRIb and
silencing of both FcεRIb variants except that the shMS4A2v3
construct that silences both FcεRIb variants was more effective
at reducing surface FcεRIa expression. These data confirm that
FcεRIb is required for surface expression of FcεRI.
Different Roles for FcεRIb Variants in Ag/IgE-Dependent
and Ag/IgE-Independent Degranulation
Because FcεRI expression was reduced with silencing of both
FL-FcεRIb and t-FcεRIb variants, we examined the manifesta-
tions of FcεRIb silencing on MC degranulation as assessed by
b-hexosaminidase (b-hex) release. Targeting just FL-FcεRIb
(shMS4A2v2) and concurrent silencing of both FcεRIb variants
(shMS4A2v3) markedly inhibited Ag-induced degranulation in
LAD-2 HuMC (Figure 2A). The addition of SCF when challenging
MC with Ag potentiates Ag-dependent degranulation (Hundley
et al., 2004), but we found that adding SCF did not change the
degree of inhibition observed with either shRNA construct (Fig-
ure 2B). There was a strong correlation between the amount of
degranulation with each shRNA construct, FcεRIb expression
(Figure S2A), and surface FcεRIa expression (Figure S2B), sup-
porting the conclusion that inhibition of IgE-dependent degranu-
lation with the FcεRIb silencing was due to a reduction in FcεRI
expression.
As both shRNA constructs exhibited reduced degranulation
with Ag stimulation, we examined responses to IgE-independent
stimulation. LAD-2 HuMC degranulate in response to the ana-
phylatoxin C3a, which acts via the G protein-coupled receptor
C3aR (Kashem et al., 2011). In contrast to FcεRI-mediated
degranulation, C3a-induced LAD-2 HuMC degranulation was
potentiated with shMS4A2v2 silencing of FL-FcεRIb. However,
the additional targeting of the t-FcεRIb variant with shMS4A2v3
impaired degranulation induced by C3a (Figure 2C). We also
examined the effects of FcεRIb silencing on degranulation in
response to thapsigargin. Thapsigargin stimulates MC degranu-
lation through a receptor-independent mechanism by depleting
endoplasmic reticular Ca2+ stores (Thastrup et al., 1990) initi-
ating store-operated Ca2+ entry through the Ca2+ channel pro-
tein Orai1 (Ma and Beaven, 2011). There was no difference in
the degree of degranulation induced by high concentrations of
thapsigargin (>100 nM) when comparing the scramble control
cells to shMS4A2v2 silencing of FL-FcεRIb, but with sub-
maximal concentrations of thapsigargin (10 nM) degranulation
was enhanced. In contrast, thapsigargin-induced degranulation908 Immunity 38, 906–917, May 23, 2013 ª2013 Elsevier Inc.at all concentrations was reduced in cells where t-FcεRIb was
additionally silenced with shMS4A2v3 (Figure 2D). Thus, the inhi-
bition of degranulation following silencing of t-FcεRIb appeared
to be downstream of processes that regulate the Ca2+ signal.
Also, the differential effects of shMS4A2v2 and shMS4A2v3
on LAD-2 HuMC IgE-independent degranulation supported
our supposition that comparative studies with both constructs
could adequately unmask the functional consequences of
t-FcεRIb depletion even though t-FcεRIb itself could not be
selectively silenced.
The potentiation of IgE-independent degranulation following
silencing of FL-FcεRIb suggests that FcεRIb may have an inhib-
itory role in this circumstance. To test this further, we overex-
pressed FL-FcεRIb and t-FcεRIb in LAD-2 HuMC and tested
the effects on degranulation in response to both Ag and thapsi-
gargin. We found that overexpression of FL-FcεRIb reduced
degranulation, whereas overexpression of t-FcεRIb potentiated
degranulation with both Ag (Figure 2E) and thapsigargin (Fig-
ure 2F). To determine whether this was also true in nontrans-
formed HuMC, we overexpressed FL-FcεRIb in human lung
MC (HLMC) as described (Cruse et al., 2010) and then activated
the cells with anti-IgE. Under these conditions, histamine release
was also attenuated compared to control cells (Figure S2C). This
supports previous studies that show that although FL-FcεRIb
is required for surface expression of FcεRI, it can also inhibit
degranulation (Furumoto et al., 2004; Gimborn et al., 2005).
Conversely, overexpression of t-FcεRIb potentiated degranula-
tion in LAD-2 HuMC (Figure S2D). In addition, silencing of both
FcεRIb variants in HLMC attenuated degranulation in response
to both anti-FcεRI and thapsigargin (Figure S2E). These studies
collectively demonstrate differential roles for FcεRIb isoforms in
both IgE-dependent and -independent degranulation.
Targeting of t-FcεRIb Inhibits Production
of Interleukin-8 but Not PGD2
Because FcεRIb isoforms have differing roles in the induction of
HuMC degranulation, we conducted similar studies on the de
novo generation of PGD2. Ag-induced PGD2 synthesis was
impaired with silencing of FL-FcεRIb or both FcεRIb variants
(Figure 2G). C3a did not induce significant release of PGD2 in
any of these conditions (Figure 2H). However, in marked contrast
to degranulation, there were no significant differences between
either of the shRNA constructs and the scramble control (Fig-
ure 2I). Due to the discordance between degranulation and
PGD2 generation upon thapsigargin stimulation, we next exam-
ined interleukin-8 (IL-8) production. We were unable to detect
IL-8 release with Ag or C3a stimulation in the LAD-2 HuMC
(data not shown). However, IL-8 production in response to thap-
sigargin stimulation was potentiated with silencing of FL-FcεRIb
with shMS4A2v2 when compared to control, whereas additional
silencing of t-FcεRIb with shMS4A2v3 inhibited thapsigargin-
induced IL-8 release (Figure 2J). These data are consistent
with the conclusion that silencing of the t-FcεRIb variant inhibits
degranulation and the release of IL-8 but not PGD2 production.
Effect of Targeting FcεRIb and t-FcεRIb
on Ca2+ Signaling
We next examined the effects of silencing FcεRIb variants on
Ca2+ signals. There was a significant reduction in the ability of
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Figure 2. Multiple Roles for FcεRIb in MC Degranulation
(A) Both shMS4A2v2 and shMS4A2v3 inhibit antigen-induced b-hex release from LAD-2 HuMC to a similar degree.
(B) Addition of 100 ng/ml SCF increased b-hex release, but did not affect the degree of inhibition.
(C) IgE-independent degranulation induced by C3a was enhanced with FL-FcεRIb targeting (shMS4A2v2, red bars) but was inhibited with silencing of both
variants of FcεRIb (shMS4A2v3, green bars).
(D) Similarly, receptor-independent thapsigargin-induced b-hex release was potentiated with FL-FcεRIb silencing at submaximal doses, but silencing both
variants significantly reduced degranulation. Data are means ± SEM from four to six experiments. *p < 0.05.
(E and F) Overexpression of FL-FcεRIb inhibits antigen-induced (E) and thapsigargin-induced (F) degranulation in LAD-2 HuMC while overexpression of t-FcεRIb
potentiates degranulation. Histograms demonstrate GFP expression assessed by FACS analysis prior to the assays.
(G) Both shMS4A2v2 and shMS4A2v3 inhibited antigen-induced PGD2 release with similar efficacy to b-hex release.
(H) C3a did not induce PGD2 release.
(I) Thapsigargin-induced PGD2 release was not affected by either shMS4A2v2 or shMS4A2v3.
(J) IL-8 release induced by thapsigargin was potentiated with FL-FcεRIb silencing and significantly inhibited with shMS4A2v3.
(K and L) Ca2+ influx was reduced in antigen-stimulated cells in the absence (K) and presence (L) of 100 ng/ml SCF, which was comparable to mediator release.
(M) Ca2+ release from stores in response to thapsigargin wasmeasured in Ca2+-freemedium andwas unaffected by either shRNA construct. Store-operated Ca2+
entry was then assessed by the addition of extracellular Ca2+ and modest reductions in Ca2+ influx with the shRNA constructs were observed. Data are the
means ± SEM from three experiments (E–J) *p < 0.05. Ca2+ imaging data are representative of two separate experiments performed in duplicate (K–M).
See also Figure S2.
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Figure 3. Effects of FcεRIb Silencing on LAD-2 HuMC Signaling
(A) LAD-2 HuMCwere either stimulated with Ag (100 ng/ml), C3a (1000 ng/ml),
or SCF (100 ng/ml) or mock-treated for 2 min. Immunoblots demonstrating a
small reduction in both PLCg1 and Akt phosphorylation with Ag stimulation
with both shMS4A2v2 and shMS4A2v3 are shown. There were no significant
differences with C3a and SCF stimulation. A similar pattern was observed with
MAPK (Jnk and ERK1/ERK2) phosphorylation. However, with the shMS4A2v3
cells, there was a reduction in Jnk phosphorylation with C3a and with SCF
stimulation. There was no obvious difference in SHIP-1 phosphorylation with
either shRNA construct.
(B) Immunoblots demonstrating that there was increased phosphorylation of
MAPKs with shMS4A2v2, but there was no difference between the
shMS4A2v3 and control after stimulation with 100 nM thapsigargin for 2 min.
Numbers represent the relative phosphorylation compared to scramble con-
trol by using densitometry with correction against total protein. Immunoblots
are representative of at least two independent experiments.
See also Figure S3.
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Truncated FcεRIb Regulates Mast Cell DegranulationAg to increase intracellular Ca2+ either in the absence (Figure 2K)
or presence of 100 ng/ml SCF (Figure 2L) with silencing of
FL-FcεRIb or both variants of FcεRIb. However, this reduction
was greater with silencing of both FcεRIb variants with910 Immunity 38, 906–917, May 23, 2013 ª2013 Elsevier Inc.shMS4A2v3. These data may reflect the larger reduction in
FcεRIa surface expression and Ag sensitivity with shMS4A2v3
over shMS4A2v2 (as in Figure S1). Release of Ca2+ from intra-
cellular stores was unaffected by gene-silencing (Figure 2M).
However, induction of Ca2+ influx with thapsigargin was reduced
when FL-FcεRIb was silenced and a more marked reduction in
Ca2+ influx was evident with silencing of both FcεRIb variants
(Figure 2M). Although Ca2+ influx was impaired with silencing
of both FcεRIb variants when compared to controls, the relatively
small effect on Ca2+ would be insufficient for the degree of
inhibition of degranulation, suggesting that the mechanism of
inhibition of degranulation and IL-8 production following gene-
silencing of both FcεRIb variants was not primarily due to defec-
tive Ca2+ signaling but rather to impediments in downstream or
Ca2+-independent signaling events.
Silencing t-FcεRIb Does Not Suppress IgE-Independent
Early Mast Cell Signaling Events
Given the profound effects on degranulation, we tested whether
FcεRI-dependent signaling events such as phosphorylation of
phospholipase Cg1 (PLCg1), Akt (a surrogate marker for phos-
phatidylinositol-3-kinase [PI3K] activation), and mitogen-acti-
vated protein kinases (MAPK) are similarly compromised with
silencing of FcεRIb in LAD-2 HuMC. The data revealed a reduc-
tion in PLCg1 phosphorylation with targeting of FL-FcεRIb and
with silencing of both variants of FcεRIb when stimulated with
Ag (Figures 3A; Figure S3A). There was also a reduction in
Ag-induced Akt phosphorylation particularly with silencing of
both FcεRIb variants (Figures 3A; Figure S3B). The effects of
silencing FcεRIb on FcεRI-dependent signaling were also
evident at the MAPK level with a reduction in phosphorylation
of c-Jun N-terminal kinases (JNK) (Figure S3C) and extracellular
signal-related kinases 1 and 2 (ERK1/ERK2) (Figure S3D), partic-
ularly when both variants were silenced (Figure 3A). Importantly,
IgE-independent signaling initiated by either C3a or SCF
remained intact at all levels although there was a reduction in
SCF-induced PLCg1 phosphorylation (Figure 3A; Figure S3A).
We also examined the FcεRIb-dependent phosphorylation of
SH2 containing inositol phosphatase (SHIP)-1, which negatively
regulatesMC signaling and cytokine production (Furumoto et al.,
2004). However, there was no significant reduction in SHIP-1
phosphorylation (Y1020) with silencing of either FL-FcεRIb alone
or both variants of FcεRIb when compared to scrambled control
(Figure 3A; Figure S3E).
Earlier we attributed the marked reduction in FcεRI-inde-
pendent thapsigargin-induced degranulation following silencing
of both variants of FcεRIb to reduced expression of t-FcεRIb.
Thus, we examined the effects of silencing on thapsigargin-
induced signaling. Thapsigargin did not induce phosphorylation
of Akt kinase or PLCg1 (data not shown). However, phosphor-
ylation of the MAPK’s ERK1 and ERK2, JNK and p38 was
apparent (Figure 3B compared to unstimulated in Figure 3A)
and indeed were potentiated when FL-FcεRIb was silenced
(Figure 3B). Nevertheless, simultaneous silencing of both
FcεRIb variants had no effect on MAPK phosphorylation and
silencing of either FL-FcεRIb or both variants did not affect
SHIP1 phosphorylation (Figure 3B). Taken together, the
signaling data demonstrate a reduction in Ag-induced signal-
ing but no reduction in IgE-independent signaling with gene
Immunity
Truncated FcεRIb Regulates Mast Cell Degranulationtargeting. This suggests that any defects in signaling that could
not be accounted for by a reduction in FcεRI expression were
minimal.
T-FcεRIb Coimmunoprecipitates with Gab2, Fyn,
and Calmodulin
Because the defect in MC degranulation was attributed to
t-FcεRIb silencing but appeared to be independent of the
early signaling events including Ca2+ mobilization, we also
examined the sequence of t-FcεRIb for domains that could
bind Ca2+-sensing proteins (Figures S4A and S4B). Calmodulin
(CaM) is a Ca2+-binding protein that changes conformation
when bound to Ca2+ and is essential for Ca2+-mediated MC
degranulation (Funaba et al., 2003). By using the Calmodulin
Target Database prediction tool (http://calcium.uhnres.
utoronto.ca/ctdb/ctdb/sequence.html), we determined that
both variants of FcεRIb contained a putative CaM-binding site
(Figures S4A–S4D). However, this region would be obscured
by the plasma membrane in the FL-FcεRIb (Figure S4C).
Conversely, the truncation of FcεRIb, which results in the loss
of the first two transmembrane domains, exposes this region
for binding CaM (Figure S4D). The potential CaM-binding site
and adjacent putative N myristoylation site, in particular, are
highly conserved in human and mouse t-FcεRIb suggesting
a functional significance for these domains (Figure S4E). There-
fore, we examined the ability of t-FcεRIb to bind CaM by
probing LAD-2 HuMC lysates with a GFP:t-FcεRIb chimeric
protein. We found that chimeric GFP:t-FcεRIb pulled down
CaM when added to the LAD-2 HuMC lysates, whereas pull-
down with GFP itself did not (Figures 4A and 4B). In addition,
CaM pull-down was markedly increased in the presence of
Ca2+ (Figure 4A). We also probed the coimmunoprecipitates
for phosphorylated tyrosine residues and found that there
was phosphorylation of proteins corresponding to about
95 kDa, 55 kDa, 45 kDa, and 40 kDa only when Ca2+ was
added (Figure 4A).
From the pull-down data and the functional data, we hypoth-
esized that t-FcεRIb was sensing Ca2+ influx and initiating
degranulation. One of the major components of MC degranula-
tion downstream of Ca2+ influx is cytoskeletal rearrangement
(Blank and Rivera, 2004), a process that is dependent upon
the Fyn kinase, Gab2, and PI3K pathway (Liu et al., 2007; Nish-
ida et al., 2005; Suzuki et al., 2010). Because Fyn kinase
(59 kDa) and Gab2 (97 kDa) correspond to the sizes of bands
seen in the pull-downs, we probed for these proteins and
found that they too were pulled down in the presence and
absence of Ca2+ (Figure 4B). We also probed for the binding
partner of Gab2, the PI3K p85 subunit and found that p85
also coimmunoprecipitated with t-FcεRIb (Figure 4B). Because
the Fyn/Gab2/PI3K pathway appears to regulate microtubule
formation (Liu et al., 2007; Nishida et al., 2005), and they
appear to interact with t-FcεRIb, we probed for a-tubulin and
found that there was a band in the t-FcεRIb pull-downs, sug-
gesting a direct interaction between the t-FcεRIb complex
and microtubules. There was also a band of 45 kDa, which
was phosphorylated when Ca2+ was added, which corre-
sponds exactly to the size of the GFP:t-FcεRIb chimera,
suggesting that the ITAM domain of t-FcεRIb could be phos-
phorylated upon binding of CaM (Figure 4A, pull-down).Although Lyn kinase has also been shown to complex to
FcεRIb (Vonakis et al., 1997), we found only a faint band on
probing for Lyn, suggesting that the t-FcεRIb complex prefer-
entially binds Fyn (as in Figure 4B) over Lyn (Figure S4F).
Another Src family kinase, Hck, which has been shown to be
important in MC degranulation (Hong et al., 2007) was also
tested but found not to form part of the t-FcεRIb complex
(Figure S4F).
To study whether CaM was binding to the putative CaM-
binding domain of t-FcεRIb, we generated CaM-binding
domain mutants of t-FcεRIb. We exchanged polar R residues
with nonpolar A residues as described in the Supplemental
Experimental Procedures (CaM mut 1). A random mutation
occurred in one clone, which resulted in an additional Y to D
mutation (CaM mut 2) (see Supplemental Experimental Proce-
dures). To test the ability of these mutants to bind CaM, we em-
ployed the same methodology as in Figures 4A and 4B and also
used a CaM sepharose 4B column to pull down CaM-binding
proteins. By using both methodologies, we identified a reduc-
tion in CaM-binding that was more marked with t-FcεRIb
CaM mut 2 (Figure 4C). We tested the functional consequence
of mutation and found that hindering CaM binding to t-FcεRIb
eliminated the potentiation of degranulation seen with WT
t-FcεRIb (Figures 4D and 4E), suggesting that binding of CaM
was critical for t-FcεRIb function in degranulation. Furthermore,
transfection of WT t-FcεRIb into LAD-2 HuMC partially recov-
ered thapsigargin-induced degranulation after silencing of
both FcεRIb variants, but transfection of t-FcεRIb CaM mut 2
did not (Figure 4F). This was more evident when degranulation
was determined by a LAMP2 assay that was gated on the GFP-
positive population (Figure 4G). Taken together, the findings
suggest that the function of t-FcεRIb in degranulation could
be dependent upon CaM binding to the putative CaM-binding
domain of t-FcεRIb.
Targeting of t-FcεRIb Results in Defective Microtubule
Formation and F-actin Dynamics
Because t-FcεRIb interacts with Gab2, PI3K, and Fyn kinase
we hypothesized that the defect in degranulation upon silencing
of t-FcεRIb was due to defective cytoskeletal rearrangement.
Therefore we examined both a-tubulin and F-actin dynamics
by using confocal microscopy in thapsigargin-stimulated
LAD-2 HuMC to bypass effects of FcεRIb silencing on surface
FcεRIa expression and Ag activation. In control cells, there
was a decrease in F-actin intensity at 2 min representing depoly-
merization of cortical F-actin. At 5 and 10 min, the intensity
markedly increased representing repolymerization (Figure 5A;
Figure S5A). Targeting of FL-FcεRIb had no effect on F-actin
depolymerization, although F-actin depolymerization was less
evident, and the subsequent increase in intensity was still
marked (Figure 5A; Figure S5A). However, with the additional
silencing of t-FcεRIb with shMS4A2v3, actin repolymerization
was delayed (Figure 5A; Figure S5A). In mBMMC, we also
observed marked depolymerization of F-actin in response to
thapsigargin challenge. However, repolymerization was not
evident by 10min in mBMMC, demonstrating different dynamics
and potentially different roles for actin in human and mouse
MC degranulation in response to thapsigargin (Figures S5B
and S5C). It was only possible to silence both FcεRIbImmunity 38, 906–917, May 23, 2013 ª2013 Elsevier Inc. 911
Figure 4. T-FcεRIb Coimmunoprecipitates with Gab2, a-Tubulin, PI3K, Fyn Kinase, and Binds Calmodulin in the Presence of Ca2+
(A) LAD-2 HuMC lysates were captured with an immunoprecipitated t-FcεRIb:GFP chimera in the absence and presence of 2 mM Ca2+ and immunoblots
demonstrated that CaMwas pulled down preferentially with t-FcεRIb in the presence of Ca2+. Probing with a phosphotyrosine Ab demonstrated phosphorylated
bands concentrated around 50–60 kDa (bottom arrow) and 80–100 kDa (top arrow) in the presence of Ca2+.
(B) Immunoblotting for Gab2 (97 kDa), PI3K p85 (85 kDa), Fyn kinase (59 kDa), and a-tubulin (55 kDa) demonstrated pull-down of these proteins with t-FcεRIb in
the presence and absence of Ca2+. Binding of CaM to the complex was again enhanced in the presence of Ca2+.
(C) Mutation of the putative CaM-binding domain of t-FcεRIb reduced CaM binding. This was particularly evident with CaM mut 2 (see text). Histograms
demonstrate equal transfection efficiencies and level of expression for each construct prior to pull-downs. Similar results were obtained with immunoprecipitated
GFP:t-FcεRIb variants used as bait for CaM, and CaM sepharose beads used to pull out CaM-binding proteins from transfected lysates. Cell lysates, after pull-
down, were run as the unbound fraction and were 53 less concentrated than the bound fraction. Immunoblots are representative of at least two independent
experiments.
(legend continued on next page)
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Figure 5. Silencing of t-FcεRIb Results in a
Deficiency in Microtubule Formation and
Cytoskeletal Dynamics
(A) 3D intensity plots demonstrating the dynamics
of filamentous (F)-actin. The top panels demon-
strate a decrease in fluorescence intensity of
phalloidin (FITC) stained LAD-2 HuMC treated with
scramble shRNA at 2 min poststimulation with
thapsigargin followed by a marked increase in in-
tensity evident at 5 and 10 min. The middle panels
and lower panels show the equivalent conditions
with silencing of FL-FcεRIb and both FL-FcεRIb
and t-FcεRIb, respectively. There was a dramatic
reduction in repolymerization of actin evident at
5 min when additional silencing of t-FcεRIb
(shMS4A2v3) was compared to scrambled control.
(B) Microtubule assembly. The top panels show the
same cells as A costained for a-tubulin. There was
a marked induction of microtubule formation with
stimulation of the scramble control and FL-FcεRIb
silenced cells showing the typical intense point
adjacent to the nucleus representing activation of
the MTOC indicative of microtubule formation.
Bottom panels show that there was a deficiency in
microtubule formation with additional silencing of
t-FcεRIb. Data are representative of several fields
from two independent experiments. Yellow scale
bar represents 20 mm. Rabbit IgG control Ab was
negative (see Figure S7).
See also Figure S5.
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Truncated FcεRIb Regulates Mast Cell Degranulationvariants in the mouse with available constructs, and there
were no differences in actin dynamics between the scrambled
control and the shMs4a2 constructs in themBMMC (Figures S5B
and S5C).
The most palpable defect in cytoskeletal dynamics with
silencing of both FcεRIb variants was a-tubulin assembly into
microtubules (Figure 5B; Figure S5D). In control cells and with
silencing of FL-FcεRIb, there was obvious formation of microtu-(D and E) Mutation of the CaM-binding domain of t-FcεRIb (CaM mut 2) eliminates the potentiation of deg
HuMC in response to both antigen (D) and thapsigargin (E). Inset shows histogram demonstrating equal ex
FACS analysis prior to assays for (D) and (E).
(F andG) Transfection ofWT t-FcεRIb, but not t-FcεRIbCaMmut 2, after silencing of both FcεRIb isoforms par
measured by b-hex release (F) and surface LAMP2 (G). Inset shows that histograms demonstrate comparab
(gray represents untransfected; black represents transfected). Data are the means ± SEM from three exper
See also Figure S4.
Immunity 38, 906–bules with the characteristic focal point
at the Microtubule Organization Center
(MTOC). The kinetics of microtubule for-
mation appeared to be faster with
silencing of FL-FcεRIb when compared
to control cells (Figure S5D). However,
most notable was the impairment of
microtubule formation when t-FcεRIb
was silenced along with FL-FcεRIb with
shMS4A2v3 (Figures 5B; Figure S5D).
This failure could thus account for the
reduction in degranulation (Figure 2A).
Silencing of both FcεRIb variants in
mBMMC also resulted in defective microtubule formation,
suggesting a conserved function for t-FcεRIb in human and
mouse MC (Figures S5E and S5F). In addition, silencing of
both FcεRIb variants in mBMMC resulted in reduced degranu-
lation in response to thapsigargin, which correlated well with
t-FcεRIb expression (Figure S5G). These data suggest that
t-FcεRIb plays a role in the regulation of microtubule formation
and degranulation in response to thapsigargin.ranulation from transfection of t-FcεRIb into LAD-2
pression of t-FcεRIb and CaM mut 2 measured by
tially recovered thapsigargin-induced degranulation
le expression levels for each transfected construct
iments (D–G).*p% 0.05, **p% 0.01, ***p% 0.001.
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Figure 6. The t-FcεRIb Complex Translo-
cates following Ca2+ Influx
(A) The t-FcεRIb:GFP chimera transfected into
LAD-2 HuMC rapidly translocates to form a ring-
like structure adjacent to the nucleus after stimu-
lation with 100 nM thapsigargin.
(B) Immunofluorescence and confocal micro-
graphs of Fyn kinase and Gab2 localization
following stimulation with 100 nM thapsigargin for
1 min. There was accumulation of both Fyn and
Gab2 to a similar location as t-FcεRIb after stimu-
lation with thapsigargin in the scramble controls
and with silencing of FL-FcεRIb. However, when
both variants of FcεRIb were silenced, perinuclear
localization was less evident.
See also Figure S6 and Movie S1.
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after Stimulation
Our data prompted us to examine the intracellular trafficking of
t-FcεRIb. We found that when the GFP:t-FcεRIb chimera was
transfected into LAD-2 HuMC, t-FcεRIb expression was distrib-
uted throughout the cell but most abundantly near the centro-
some under resting conditions. However, following stimulation
with thapsigargin, t-FcεRIb transiently translocated to a region
adjacent to the nucleus, which was rich in a-tubulin (Movie S1),
forming a circular structure around the centrosome (Figure 6A).
We stained for Fyn kinase and Gab2 in control and thapsigar-
gin-stimulated cells and found that they also accumulated in
the perinuclear region, which was more apparent with stimula-
tion (Figure 6B). This localization was less evident in cells where
both FcεRIb variants were silenced (Figure 6B). Stimulation
of LAD-2 HuMC with Ag resulted in similar localization of
t-FcεRIb to the MTOC region (Figure S6A). Ag stimulation trig-
gered recruitment of Gab2 to the plasma membrane, as well
as the MTOC (Figure S6B). However, plasma membrane recruit-
ment of Gab2 with thapsigargin stimulation was less evident
(Figure S6C).
To explore t-FcεRIb localization further, the GFP:t-FcεRIb
chimera constructs were transfected into LAD-2 HuMC and
images were acquired by confocal microscopy. Gab2 and
t-FcεRIb were observed to colocalize and form a network
concentrated around the MTOC (Figures 7A and 7B; Figure S7;
Movies S2 and S3) and centrosome (Figures 7C and 7D; Movies
S4 and S5). This colocalization was less evident with the CaM
mut 2 construct (Figures 7A and 7B; Figure S7) suggesting an914 Immunity 38, 906–917, May 23, 2013 ª2013 Elsevier Inc.important role for the putative CaM-bind-
ing domain in translocation of t-FcεRIb.
It has been demonstrated that the Golgi
apparatus is usually in close proximity to
the MTOC (Hurtado et al., 2011; Rivero
et al., 2009) and that the Golgi protein
GM130 may play a role in microtubule for-
mation (Hurtado et al., 2011; Rivero et al.,
2009). We therefore stained for GM130
and found that t-FcεRIb colocalized with
GM130 (Figure 7E), demonstrating that
the t-FcεRIb complex translocated to
the Golgi following stimulation. Thus the localization of the
t-FcεRIb-Gab2 complex to the Golgi appears to be critical for
the formation of microtubules and degranulation of HuMC.
DISCUSSION
This study demonstrates multiple roles for theMS4A2 gene that
encodes FcεRIb in HuMC function. Principally, we demonstrate
a crucial role for t-FcεRIb in that this variant translocates to
the Golgi following activation. Importantly, the translocation of
t-FcεRIb may be associated with binding of Ca2+-loaded CaM
to t-FcεRIb. This binding may facilitate phosphorylation of
substrates corresponding to Fyn kinase, Gab2, and t-FcεRIb.
Although the thesis of such a t-FcεRIb complex is in agreement
with a previous report that Gab2 complexes with Fyn and PI3K
(Parravicini et al., 2002), our data cannot rule out independent
and/or competitive binding to t-FcεRIb by kinases. However,
mutation of the CaM-binding domain of t-FcεRIb, which results
in reduction in CaM pull-down, appears to render t-FcεRIb
nonfunctional. Thus, we believe that these observations support
the construct that phosphorylation of Fyn kinase and Gab2 facil-
itates translocation of the t-FcεRIb complex to the Golgi where
it plays a role in microtubule formation in a CaM-dependent
manner promoting degranulation.
MC signaling has been extensively studied and the FcεRI-
proximal pathways involved in MC activation are largely well
defined (reviewed in Gilfillan and Rivera, 2009; Gilfillan and Tkac-
zyk, 2006; Rivera and Gilfillan, 2006). However, signaling events
downstream of Ca2+ influx are less well studied, but we know
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Figure 7. T-FcεRIb and Gab2 Colocalized to
the Golgi Apparatus, which Surrounds the
Microtubule Organization Center
(A) Confocal micrographs showing that t-FcεRIb
(green) and Gab2 (red) colocalized (yellow) to a
structure near the nucleus (top panels). CaM mut 2
t-FcεRIb exhibited reduced colocalization with
Gab2 (bottom panels and bar graph, data ex-
pressed as mean ± SD, ***p < 0.001 ANOVA).
(B) 3D reconstruction and surface rendering of
deconvolved image stacks revealed t-FcεRIb
(green) and Gab2 (purple) form a structure with
a hollow center adjacent to the bilobed nucleus
(blue). There was colocalization (yellow) only in the
region adjacent to the nucleus (top panels), which
was less evident with CaM mut 2 (bottom panels).
(C) The t-FcεRIb complex surrounds the MTOC.
Confocal micrographs demonstrating that t-FcεRIb
(green) circles the MTOC, which appears as a
dense a-tubulin (red) rich region adjacent to the
nucleus. 3D render of average intensity of the z
stack demonstrates that t-FcεRIb surrounds the
MTOC. The translocation of t-FcεRIb was less
evident with CaM mut 2 (bottom panels).
(D) 3D reconstruction of these structures revealed
that the hollow center of the t-FcεRIb (green)
structure was completely filled with a-tubulin (red).
There was little colocalization (yellow) of t-FcεRIb
and a-tubulin, but points of contact were apparent,
which could represent nucleation of microtubules
at the Golgi. It was also apparent that the centro-
some structure formed by the MTOC and t-FcεRIb
complex caused considerable indentation into the
nucleus (blue).
(E) Confocal micrographs demonstrating that
t-FcεRIb (green) forms an identical structure as the
cis-Golgi protein GM130 (red).
See also Figure S7 and Movies S2, S3, S4 and S5.
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tory granule trafficking and fusion with the plasma membrane
(Dra´ber et al., 2012; Lorentz et al., 2012). It has been demon-
strated that in addition to the requirement for Ca2+ influx, the
Fyn kinase/Gab2/PI3K pathway is critical for the formation of
microtubules and hence the trafficking of MC granules to the
cell surface (Nishida et al., 2011; Nishida et al., 2005). Our studies
provide additional details of the molecular events that may link
these critical processes and provide a plausible mechanism for
the propagation of Ca2+ signals to the cytoskeleton, thus linking
Ca2+ influx to formation of microtubules and degranulation. An
interesting observation particularly pertinent to our suggested
model is that events controlling FcεRI-dependent signaling
have distinct kinetics. Initial MC signaling events such as
PLCg1 phosphorylation and the release of Ca
2+ from intracellular
stores occur rapidly while PI3K-dependent signaling events are
more delayed (Tkaczyk et al., 2003). This suggests that the delay
may be due to a requirement for the store-dependent influx of
extracellular Ca2+, which in turn induces binding of CaM toImmunity 38, 906–t-FcεRIb and translocation to the Golgi.
Therefore, it is likely that these events
must take place before PI3K signaling
can proceed.We have demonstrated that t-FcεRIb and Gab2 colocalized to
the Golgi after MC activation and that the Golgi forms an intricate
network with the MTOC. This therefore implicates involvement
of the Golgi in microtubule formation and MC degranulation.
Recent reports have suggested that the Golgi can not only regu-
late microtubule dynamics but can also initiate nucleation of
microtubules (Hurtado et al., 2011; Rivero et al., 2009). The nucle-
ation of microtubules initiated by the Golgi requires the inter-
action between the centrosome-associated protein AKAP450
and the cis-Golgi protein GM130, which are both required
for the Golgi to form the pericentrosomal circular ribbon organi-
zation (Hurtado et al., 2011; Rivero et al., 2009) as was observed
in this study. The interaction between AKAP450 and GM130
anchors the cis-Golgi to the centrosome, and disruption of this
interaction with truncatedmutants of AKAP450 caused dissocia-
tion of the Golgi from the centrosome, which negatively affected
nucleation and secretion (Hurtado et al., 2011; Rivero et al.,
2009). Thus, the close association of t-FcεRIb and Gab2 at the
MTOC-Golgi interface may be key to t-FcεRIb function.917, May 23, 2013 ª2013 Elsevier Inc. 915
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Truncated FcεRIb Regulates Mast Cell DegranulationIt has been reportedwith EGFP-CaMchimeras that CaM trans-
locates to the MTOC after MC activation (Psatha et al., 2004).
In addition, it has also been demonstrated that in T cells, Ras
guanyl nucleotide releasing protein 1 (RasGRP1), an upstream
activator of the PI3K pathway, translocates to the Golgi upon
TCR activation where it activates Ras (Perez de Castro et al.,
2004). Our observations are consistent with these reports as
we propose that CaM binding to t-FcεRIb is critical for this
pathway. Also the phenotype of the t-FcεRIb silenced cells
closely resembles that of BMMC from RasGRP1/ mice
(Liu et al., 2007), suggesting a role for PI3K. BMMC from
RasGRP1/mice display a significant reduction in both degran-
ulation and cytokine production. In addition, there are defects
in microtubule formation, whereas F-actin rearrangement is not
affected (Liu et al., 2007). We found that whereas F-actin
dynamics were affected by silencing of t-FcεRIb in human cells,
mouse BMMC were unaffected and depolymerization of
cortical F-actin, which has been shown to be driven by Ca2+
and Ca2+-dependent kinases (Nishida et al., 2005), still occurred.
Similarly to RasGRP1/ BMMC, Fyn/, Gab2/, and PI3K/
BMMC also display deficiencies in cytoskeletal dynamics and
degranulation (Nishida et al., 2005; Suzuki et al., 2010), which
suggests that t-FcεRIb, Gab2, and RasGRP1 regulate a common
PI3K pathway that ultimately forms the microtubular network
required for granule translocation and degranulation.
This study has delineated a plausible mechanism behind a
unique function for t-FcεRIb, which may act to propagate Ca2+
signals linking Ca2+-influx to microtubule nucleation and for-
mation. We have demonstrated that t-FcεRIb binds to Gab2 and
kinasescritical formicrotubule formationand that, in thepresence
of Ca2+, CaM binds to the t-FcεRIb complex. This appears to be
central to its function, possibly initiating phosphorylation and
localization to the pericentrosome and Golgi. The potential roles
of FcεRIb in HuMC function are particularly important because
theMS4A2 gene is considered a candidate gene for the develop-
ment of allergy and based upon the data presented in this study,
the gene product t-FcεRIb is a plausible candidate. Thus the
potential linkage of polymorphisms and/or mutations in t-FcεRIb
with allergy warrants further investigation. Furthermore, given
the mechanism and binding partners of t-FcεRIb, we predict
that the t-FcεRIb complex represents an excellent drug target
for allergy and asthma, whichwould presumably beMC-specific.
EXPERIMENTAL PROCEDURES
All human subjects gavewritten informed consent and the studywas approved
by the Leicestershire Research Ethics Committee, UK. Experiments on mice
were conducted under a protocol approved by the Animal Care and Use
Committee at National Institutes of Health (NIH).
Viral Transduction of Mast Cells
For gene silencing in LAD-2 HuMC, MISSION shRNA constructs and lentivi-
ruses were used (Sigma-Aldrich, St. Louis, MO) as described (Kuehn et al.,
2010). For constructs see Supplemental Experimental Procedures. For over-
expression in HLMC, a custom-made Ad5C20Att01 virus containing the
clone for FL-FcεRIb (BioFocus DPI, Leiden, the Netherlands) was used as
described (Cruse et al., 2010).
Immunoblotting
For details of antibodies used, see Supplemental Experimental Procedures.
For immunoblotting, LAD-2 HuMC were sensitized with 100 ng/ml bio-916 Immunity 38, 906–917, May 23, 2013 ª2013 Elsevier Inc.tinylated IgE overnight in LAD-2 medium without SCF (Kuehn et al., 2011).
Cells were then washed twice in HEPES buffer containing 0.04% BSA and
resuspended at 2.5 3 106 cells/ml of HEPES buffer containing 0.04%
BSA. The cells were challenged for 2 min with the indicated stimuli and
then immediately lysed as described (Smrz et al., 2010). Immunoblots were
carried out on the total cell lysates as described (Smrz et al., 2010). We
analyzed the acquired images and performed the densitometry by using Im-
ageJ software (version 1.32).
Flow Cytometry
To assay surface expression of FcεRIa and KIT, we used flow cytometric anal-
ysis on the FacsCalibur machine (BD Biosciences, San Jose, CA). Data were
acquired with double staining for CD117 and FcεRIa. For some experiments,
LAD-2 HuMC were transfected with GFP fusion constructs as described
(Cruse et al., 2010).
Mediator Release Assays
For MC degranulation, b-hex was measured as described (Kuehn et al., 2011).
Histamine measurements were performed by radioenzymatic assay as
described (Sanmugalingam et al., 2000). PGD2-MOX (Cayman Chemicals,
Ann Arbor, MI) and IL-8 (R&D Systems, Minneapolis, MN) were assayed as
described (Kuehn et al., 2011) and according to the manufacturer’s
instructions.
Measurement of Intracellular Ca2+
Changes in cytosolic Ca2+ levels were determined in SCF-deprived LAD-2
HuMC following loading of the cells with Fura-2 AM ester (Molecular Probes,
Eugene, OR) as described (Tkaczyk et al., 2003). Fluorescence was
measured at two excitation wavelengths (340 and 380 nm) and an emission
wavelength of 510 nm. The ratio of the fluorescence readings was calculated
following subtraction of the fluorescence of the cells that had not been
loaded with Fura-2 AM.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures, Supplemental Experimental
Procedures, and five movies and can be found with this article online at http://
dx.doi.org/10.1016/j.immuni.2013.04.007.
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